Jaguar Health (JAGX) Trading Down 4.2%
Jaguar Health Inc (NASDAQ:JAGX)’s share price traded down 4.2% during mid-day trading on Monday . The stock traded as low as $0.23 and last traded at $0.23. 70,503 shares were traded during mid-day trading, a decline of 100% from the average session volume of 18,383,772 shares. The stock had previously closed at $0.24.
Separately, ValuEngine downgraded Jaguar Health from a “buy” rating to a “hold” rating in a research report on Thursday, January 24th.
The company has a debt-to-equity ratio of 1.03, a current ratio of 0.46 and a quick ratio of 0.31.
Jaguar Health Company Profile (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
See Also: Trading signals using Bollinger bands
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.